Form 4: Columbia Financial, Inc. Executive Jenifer White Walden Reports Acquisition of Common Stock and Stock-Based Deferral Plan Activity
SEC Form 4 Filing
EVP & CHRO of Columbia Financial, Inc., Jenifer White Walden, reports acquiring common stock through a stock-based deferral plan and updates on stock awards and options.
Summary
- On September 6, 2024, Jenifer White Walden, EVP & CHRO of Columbia Financial, Inc., reported transactions involving Columbia Financial, Inc. [CLBK] securities.
- Walden acquired common stock through a stock-based deferral plan at a price of $16.99 per share, totaling 31.3531 shares.
- Walden directly owns 1,359 shares of common stock.
- Walden indirectly owns shares through various plans including ESOP (982 shares), SERP (45 shares), SIM (14 shares), Stock Award (1,298 shares), Stock Award II (7,817 shares), and Stock Award III (7,597 shares).
- Walden holds stock options to buy 5,540 shares at $20.54 (exercisable from October 31, 2023), 6,203 shares at $15.94 (exercisable from May 1, 2024), and 5,107 shares at $16.49 (exercisable from March 6, 2025).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions by an executive. The acquisition of shares through the deferral plan is a slightly positive signal.
Positives
- The acquisition of shares through the stock-based deferral plan indicates Walden's continued investment in the company's future.
- The vesting schedules of stock awards and options provide long-term incentives for Walden.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedules of stock awards and options suggest a continued alignment of Walden's interests with the company's long-term performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and potential alignment with shareholder interests.
Stakeholder Impact
- The reported transactions provide transparency to shareholders regarding executive compensation and alignment of interests.
- Employees participating in the ESOP, SERP, and SIM plans are indirectly affected by the reported holdings.
Key Dates
| Date | Description |
|---|---|
| 10/31/2023 | Commencement of vesting for stock options with an exercise price of $20.54. |
| 05/01/2024 | Commencement of vesting for stock options with an exercise price of $15.94 and 25% of Stock Awards II. |
| 09/06/2024 | Date of transaction for common stock acquisition through stock-based deferral plan. |
| 09/09/2024 | Date of signature by Power of Attorney. |
| 03/06/2025 | Commencement of vesting for stock options with an exercise price of $16.49 and 25% of Stock Awards III. |
| 05/01/2033 | Expiration date for stock options with an exercise price of $15.94. |
| 03/06/2034 | Expiration date for stock options with an exercise price of $16.49. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.